Transitional cell carcinoma of the ovary

Taiwanese Journal of Obstetrics and Gynecology

Volumn 45, Issue 3, 2006, Pages 268-271

  Lin, Chia Hui ^a   Liu, Fu Shing ^a   Ho, Esther Shih Chu ^a  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Ovary; transitional cell carcinoma

Indexed keywords

CARBOPLATIN; CYCLOPHOSPHAMIDE;

ABDOMINAL HYSTERECTOMY; AGED; ANAMNESIS; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURGERY; CASE REPORT; CLINICAL FEATURE; COLOR ULTRASOUND FLOWMETRY; COMPUTER ASSISTED TOMOGRAPHY; ECHOGRAPHY; FEMALE; HEALTH CENTER; HOSPITAL ADMISSION; HUMAN; IMMUNOHISTOCHEMISTRY; LABORATORY TEST; MICROSCOPY; OUTPATIENT DEPARTMENT; OVARY CARCINOMA; PELVIS LYMPHADENECTOMY; PHYSICAL EXAMINATION; POSTMENOPAUSE; SALPINGOOOPHORECTOMY; TRANSITIONAL CELL CARCINOMA;

EID: 33749503054     PISSN: 10284559     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1028-4559(09)60240-0     Document Type: Article

References (12)

1. Silva EG, Robey-Cafferty SS, Smith TL, Gershenson DM. Ovarian carcinomas with transitional cell carcinoma pattern. Am J Clin Pathol 1990;93:457-65.
2. Austin RM, Norris HJ. Malignant Brenner tumor and transitional cell carcinoma of the ovary: a comparison. Int J Gynecol Pathol 1987;6:29-39.
3. Ayhan A, Tuncer ZS, Sarac E, Ayhan A. Transitional cell carcinoma of the ovary. Int J Gynecol Cancer 1996;6:183-5.
4. Eichhorn JH, Young RH. Transitional cell carcinoma of the ovary: a morphologic study of 100 cases with emphasis on differential diagnosis. Am J Surg Pathol 2004;28:453-63.
5. Croft PR, Lathrop SL, Feddersen RM, Joste NE. Estrogen receptor expression in papillary urothelial carcinoma of the bladder and ovarian transitional cell carcinoma. Arch Pathol Lab Med 2005;129:194-9.
6. Shen K, Lang J, Guo L. Overexpression of p53 in transitional cell carcinoma of the ovary. Zhonghua Fu Chan Ke Za Zhi 1995;30:153-6.
7. Gershenson DM, Baker W, Price JE, Hung MC, Naggar AK, Tortolero LG, Silva EG. Molecular profile of advanced-stage transitional cell carcinoma of the ovary. Am J Obstet Gynecol 1997;177:120-5.
8. Shen K, Lang J, Guo L. Overexpression of C-erbB3 in transitional cell carcinoma of the ovary. Zhonghua Fu Chan Ke Za Zhi 1995;30:658-61.
9. Sweeten KM, Gershenson DM, Burke TW, Mitchell M, Charles L, Silva EG. Salvage chemotherapy for refractory transitional cell carcinoma of the ovary. Gynecol Oncol 1995;59:211-5.
10. Gershenson DM, Silva EG, Mitchell M, et al. Transitional cell carcinoma of the ovary: a matched control study of advanced-stage patients treated with cisplatin-based chemotherapy. Am J Obstet Gynecol 1993;168:1178-85.
11. Kommoss F, Kommoss S, Schmidt D, Trunk MJ, Pfisterer J, du Bois A. Survival benefit for patients with advanced-stage transitional cell carcinomas vs. other subtypes of ovarian carcinoma after chemotherapy with platinum and paclitaxel. Gynecol Oncol 2005;97:195-9.
12. Hollingsworth HC, Steinberg SM, Silverberg SG, Merino MJ. Advanced stage transitional cell carcinoma of the ovary. Hum Pathol 1996;27:1367-72.